Nano Dimension Ltd. (NNDM) Form SCHEDULE 13D/A — Jun 17, 2026
Oramed Pharmaceuticals Inc., the reporting person in this Schedule 13D/A amendment, has engaged in significant open market accumulation of Nano Dimension Ltd. shares. The filing details a series of transactions occurring between May 13, 2026, and June 15, 2026, reflecting an aggressive buying strategy. During the specified period, Oramed Pharmaceuticals acquired a total of 6,336,565 shares, with the largest single transaction taking place on June 15, 2026, involving the purchase of 5,000,000 shares at a price of $1.27 per share.
Key figures
- Lowest Purchase Price
- $1.27
- Highest Purchase Price
- $1.73
- Average Purchase Volume
- Heavy
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.